On the contrary, some phytoestrogens, like soy isoflavones, have been demonstrated to have a protective influence, reducing the risk of the disease, most likely by affecting ERβ, which would exert anti-proliferative results in some subtypes of breast cancers [38]. Here, ESR2 is linked to breast carcinoma.